Display options
Share it on

Gynecol Oncol Rep. 2014 Oct 27;10:30-1. doi: 10.1016/j.gore.2014.10.002. eCollection 2014 Dec.

Breast cancer in the setting of fertility-sparing treatment for endometrial cancer.

Gynecologic oncology reports

Haley A Moss, Melissa K Frey, Stephanie V Blank

Affiliations

  1. New York University Langone Medical Center, United States.

PMID: 26075999 PMCID: PMC4434147 DOI: 10.1016/j.gore.2014.10.002

Abstract

•Progesterone therapy is a commonly used alternative to surgical management for women with endometrial cancer who desire fertility preservation.•Prior research suggests that progestins may contribute to breast tumorigenesis.•We report a patient diagnosed with progesterone receptor positive breast cancer during hormonal treatment of endometrial cancer.

Keywords: Breast cancer; Endometrial cancer; Fertility-sparing; Hormonal therapy

References

  1. Int J Gynecol Cancer. 2014 May;24(4):718-28 - PubMed
  2. Gynecol Oncol. 2014 May;133(2):229-33 - PubMed
  3. Menopause. 2011 Aug;18(8):845-50 - PubMed
  4. Lancet. 2003 Aug 9;362(9382):419-27 - PubMed
  5. JAMA. 2013 Oct 2;310(13):1353-68 - PubMed
  6. Gynecol Oncol. 2012 May;125(2):477-82 - PubMed
  7. J Clin Oncol. 1999 Jun;17(6):1736-44 - PubMed
  8. Obstet Gynecol. 1984 Sep;64(3):417-20 - PubMed
  9. Gynecol Oncol. 2004 Oct;95(1):133-8 - PubMed
  10. Endocr Rev. 2013 Feb;34(1):130-62 - PubMed

Publication Types